A high serum soluble Fas/APO-1 level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma

scientific article published on 01 September 1999

A high serum soluble Fas/APO-1 level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1024724621
P356DOI10.1038/SJ.LEU.2401502
P2888exact matchhttps://scigraph.springernature.com/pub.10.1038/sj.leu.2401502
P698PubMed publication ID10482996

P2093author name stringK Sasaki
M Umeda
N Niitsu
P433issue9
P304page(s)1434-1440
P577publication date1999-09-01
P1433published inLeukemiaQ6534498
P1476titleA high serum soluble Fas/APO-1 level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma
P478volume13

Reverse relations

cites work (P2860)
Q47657395Emerging mechanisms of long noncoding RNA function during normal and malignant hematopoiesis
Q34419383FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.
Q49648834Fas-Antisense Long Noncoding RNA and Acute Myeloid Leukemia: Is There any Relation?
Q90101887Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy
Q77492326High serum soluble CD44 is correlated with a poor outcome of aggressive non-Hodgkin's lymphoma
Q39104939Immunobiology of Long Noncoding RNAs.
Q34616243Long non-coding RNAs and control of gene expression in the immune system
Q35040346Ran GTPase-activating protein 1 is a therapeutic target in diffuse large B-cell lymphoma
Q33553314Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma
Q26798158Splicing Regulators and Their Roles in Cancer Biology and Therapy
Q97072562The role of Long Non-Coding RNAs (lncRNAs) and downstream signaling pathways in Leukemia progression

Search more.